IDR 1060.0
(-2.3%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 263.69 Billion IDR | -34.5% |
2022 | 402.57 Billion IDR | -30.49% |
2021 | 579.12 Billion IDR | 144.57% |
2020 | 236.79 Billion IDR | 51.38% |
2019 | 156.42 Billion IDR | 7.79% |
2018 | 145.11 Billion IDR | 60.76% |
2017 | 90.26 Billion IDR | 89.77% |
2016 | 47.56 Billion IDR | 42.87% |
2015 | 33.29 Billion IDR | 26.7% |
2014 | 26.27 Billion IDR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 118.08 Billion IDR | -3.13% |
2024 Q2 | 121.89 Billion IDR | 9.01% |
2024 Q1 | 111.81 Billion IDR | 33.88% |
2023 Q3 | 59.42 Billion IDR | -3.66% |
2023 FY | 263.69 Billion IDR | -34.5% |
2023 Q1 | 59.07 Billion IDR | -92.07% |
2023 Q2 | 61.68 Billion IDR | 4.41% |
2023 Q4 | 83.52 Billion IDR | 40.55% |
2022 Q2 | 133.61 Billion IDR | -34.82% |
2022 Q3 | -681.26 Billion IDR | -609.86% |
2022 Q4 | 745.22 Billion IDR | 209.39% |
2022 FY | 402.57 Billion IDR | -30.49% |
2022 Q1 | 204.99 Billion IDR | 38.44% |
2021 Q3 | 191.43 Billion IDR | 48.42% |
2021 FY | 579.12 Billion IDR | 144.57% |
2021 Q4 | 148.07 Billion IDR | -22.65% |
2021 Q1 | 110.63 Billion IDR | 17.49% |
2021 Q2 | 128.97 Billion IDR | 16.58% |
2020 Q1 | 40.83 Billion IDR | 6.41% |
2020 Q2 | 38.73 Billion IDR | -5.15% |
2020 FY | 236.79 Billion IDR | 51.38% |
2020 Q4 | 94.16 Billion IDR | 49.31% |
2020 Q3 | 63.06 Billion IDR | 62.83% |
2019 Q4 | 38.37 Billion IDR | -4.8% |
2019 FY | 156.42 Billion IDR | 7.79% |
2019 Q3 | 40.31 Billion IDR | 1.89% |
2019 Q2 | 39.56 Billion IDR | 3.64% |
2019 Q1 | 38.17 Billion IDR | -5.18% |
2018 Q3 | 40.09 Billion IDR | 23.03% |
2018 FY | 145.11 Billion IDR | 60.76% |
2018 Q4 | 40.25 Billion IDR | 0.42% |
2018 Q1 | 32.17 Billion IDR | 21.98% |
2018 Q2 | 32.58 Billion IDR | 1.26% |
2017 FY | 90.26 Billion IDR | 89.77% |
2017 Q1 | 12.92 Billion IDR | -43.34% |
2017 Q2 | 20.83 Billion IDR | 61.22% |
2017 Q3 | 30.11 Billion IDR | 44.52% |
2017 Q4 | 26.38 Billion IDR | -12.41% |
2016 Q3 | 11.99 Billion IDR | 89.29% |
2016 FY | 47.56 Billion IDR | 42.87% |
2016 Q2 | 6.33 Billion IDR | 0.0% |
2016 Q1 | 6.33 Billion IDR | 0.0% |
2016 Q4 | 22.81 Billion IDR | 90.18% |
2015 FY | 33.29 Billion IDR | 26.7% |
2014 FY | 26.27 Billion IDR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | 8.38 Billion IDR | -3043.493% |
PT Jayamas Medica Industri Tbk | 551.99 Billion IDR | 52.229% |
Maja Agung Latexindo Tbk. | 14.93 Billion IDR | -1665.703% |